Foghorn Therapeutics (FHTX) Leases (2020 - 2025)
Foghorn Therapeutics (FHTX) has 6 years of Leases data on record, last reported at $30.9 million in Q4 2025.
- For Q4 2025, Leases rose 36.69% year-over-year to $30.9 million; the TTM value through Dec 2025 reached $30.9 million, up 36.69%, while the annual FY2025 figure was $30.9 million, 36.69% up from the prior year.
- Leases reached $30.9 million in Q4 2025 per FHTX's latest filing, up from $10.2 million in the prior quarter.
- Across five years, Leases topped out at $39.6 million in Q3 2021 and bottomed at $400000.0 in Q1 2021.
- Average Leases over 5 years is $26.1 million, with a median of $30.5 million recorded in 2023.
- Peak YoY movement for Leases: surged 9250.5% in 2022, then plummeted 57.71% in 2025.
- A 5-year view of Leases shows it stood at $38.5 million in 2021, then decreased by 11.5% to $34.1 million in 2022, then fell by 12.12% to $30.0 million in 2023, then decreased by 24.42% to $22.6 million in 2024, then skyrocketed by 36.69% to $30.9 million in 2025.
- Per Business Quant database, its latest 3 readings for Leases were $30.9 million in Q4 2025, $10.2 million in Q3 2025, and $10.9 million in Q2 2025.